eyeforpharma
  Real World Evidence 2013 October 16-17 | Bethesda, MD
Fill out the form below to get the brochure sent straight to your inbox.
First Name*
Last Name*
Email Address*
Job Title*
Company Name*
Telephone*
Country*
Business Type*

Download Your e-Brochure Now

The Brochure

Please fill in your information to be the first to receive the detailed 8 page brochure

How you will benefit from Real World Evidence 2013:

  • Promote relative effectiveness, build strategic partnerships, and bring therapies to market – Case Studies from Tehseen Salimi - VP of Global Value & Evidence Development at Sanofi, David Memel - VP of HEOR at Boehringer Ingelheim, Marc Berger - VP of Real World Data & Analytics at Pfizer & Brian Bradbury – Director, Center for Observational Research at Amgen
  • Enhance your payer relationships by meeting them in person.  Leaders you’ll meet include the EVP/CCO of United Healthcare, Sam Ho M.D.; Stephen B. Bonner, President and CEO, Cancer Treatment Centers of America; Steve Chick, Market Vice President at Humana & Lucius F. Wright M.D., Nephrologist, The Jackson Clinic
  • Know how US healthcare IT changes impact your data collection methods.  NIH OBSSR Director Robert Kaplan delivers a Case Study will show the new generation of analysis methods to deal with massive EMR datasets - Harmonize your data-capture strategy.
  • Policy changes can critically effect your evidence generation investments. Meet D.C. insiders - an advisor to the Senate Health Committee speaks on the release of Medicare and Medicaid claims data, commercialization and path to market success. Also hear an exclusive case study industry perspective from Johnson & Johnson Senior Director – Health Policy, Robert Donnelly.
  • Discover treasure troves of Provider/ACO data-sets to understand why they are interested in collaborating with pharma on the evidence generated about the real-world effects of medical treatmentsfrom Brian Wells, AVP at Penn Medicine, John Lynch, Executive Director at CT Center for Primary Care & Mohit Kaushal, Partner at Aberdare Ventures (ex-CSO at West Health)
  • Understand the real-world data opportunities and challenges in emerging markets in Asia and globally from Joe DiCesare, VP Global HEOR at Novartis & Jason Liu, Global Head HEOR at Pfizer.

Please fill in your information to be the first to receive the detailed 8 page brochure

Pfizer Novartis HHS US Senate
Johnson & Johnson Sanofi Tufts UMC Aetna
Harvard Kaiser Permanente Amgen Boehringer Ingelheim

 Testimonials

"The expertise of the various speakers and the relevance of the discussion topics made the conference worthwhile and an opportunity for learning."

Brian Bradbury, Director - Center for Observational Research, Amgen

“A good networking & learning opportunity on topics essential for healthcare improvement. This meeting has global experts willing to share the spirit of open innovation. The panel discussions offer valuable insights with relevant and pragmatic content.”

Tehseen Salimi, VP Global Evidence and Value Development, Sanofi

"EyeforPharma is my "go to" source for consistently high quality, reliable information regarding the rapidly evolving global healthcare
market place."

Jill Sackman, Senior Consultant, NAI

Dane Disimino
Dane Disimino
Global Conference Director
eyeforpharma
Tel: 201.204.1677
E: dane@eyeforpharma.com

LinkedIn: Dane Disimino
Twitter: @RealWorldData
Theo Fellgett
Theo Fellgett
VP North America
eyeforpharma
Tel: 201.234.4802
E: theo@eyeforpharma.com

LinkedIn: Theo Fellgett
Global Sponsors
Cegedim
optum
Gold Sponsor
PWC
Panel Sponsor
Numerof & Associates